IM Cannabis (IMCC) Total Current Liabilities (2019 - 2026)
IM Cannabis (IMCC) posted quarterly Total Current Liabilities of $20.2 million for Q1 2026, down 28.9% year-over-year from $28.4 million in Q1 2025, and down 17.11% quarter-over-quarter from $24.4 million in Q4 2025.
IM Cannabis (IMCC) Total Current Liabilities (2019 - 2026) Analysis & Trends
IM Cannabis' Total Current Liabilities history runs 8 years deep, the most recent figure standing at $20.2 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 28.9% year-over-year to $20.2 million; the TTM figure through Mar 2026 stood at $20.2 million (down 28.9% YoY), while the FY2025 annual figure was $24.4 million, down 4.39% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $20.2 million, down from $24.4 million in the prior quarter.
- The five-year high for Total Current Liabilities was $53.1 million in Q3 2022, with the low at $19.3 million in Q1 2023.
- The 5-year median for Total Current Liabilities is $24.9 million (2022), against an average of $28.0 million.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities plunged 60.66% in 2023, then jumped 37.75% in 2024.
- IM Cannabis' Total Current Liabilities stood at $24.9 million in 2022, then fell by 3.16% to $24.1 million in 2023, then increased by 3.6% to $25.0 million in 2024, then fell by 2.44% to $24.4 million in 2025, then declined by 17.11% to $20.2 million in 2026.
- Business Quant data shows IMCC's Total Current Liabilities at $20.2 million in Q1 2026, $24.4 million in Q4 2025, and $27.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn | 21.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.23 Mn |
| Mar 31, 2026 | 20.21 Mn |
| Dec 31, 2025 | 24.39 Mn |
| Sep 30, 2025 | 27.95 Mn |
| Jun 30, 2025 | 25.37 Mn |
| Mar 31, 2025 | 28.43 Mn |
| Dec 31, 2024 | 25.00 Mn |
| Sep 30, 2024 | 28.77 Mn |
| Jun 30, 2024 | 24.42 Mn |
| Mar 31, 2024 | 22.62 Mn |
| Dec 31, 2023 | 24.13 Mn |
| Sep 30, 2023 | 20.89 Mn |
| Jun 30, 2023 | 20.92 Mn |
| Mar 31, 2023 | 19.25 Mn |
| Dec 31, 2022 | 24.91 Mn |
| Sep 30, 2022 | 53.09 Mn |
| Jun 30, 2022 | 42.01 Mn |
| Mar 31, 2022 | 43.51 Mn |
| Dec 31, 2021 | 22.38 Mn |
| Dec 31, 2020 | 4.81 Mn |